This inventor holds 1 USPTO granted patent. Top assignee: Teijin Limited. Active years: 1994.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1994
Title: Hiroshi Maruyama: Innovator in Monoclonal Antibody Research
Introduction
Hiroshi Maruyama is a prominent inventor based in Sapporo, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His work has implications for various medical applications, showcasing the importance of innovation in healthcare.
Latest Patents
Hiroshi Maruyama holds a patent for a monoclonal antibody targeting human acid-glutathione S-transferase. This invention represents a crucial advancement in the understanding and treatment of diseases related to this enzyme. The patent highlights his commitment to scientific research and innovation.
Career Highlights
Maruyama is associated with Teijin Limited, a company known for its focus on advanced materials and healthcare solutions. His role at Teijin Limited has allowed him to collaborate with other experts in the field, further enhancing his contributions to biotechnology.
Collaborations
Throughout his career, Hiroshi Maruyama has worked alongside notable colleagues such as Hideaki Suzuki and Kenji Hosoda. These collaborations have fostered a productive environment for innovation and research, leading to significant advancements in their respective fields.
Conclusion
Hiroshi Maruyama's work in monoclonal antibody research exemplifies the impact of innovation in biotechnology. His contributions continue to influence the medical field, demonstrating the importance of dedicated inventors in advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile